1. Home
  2. MGTX vs VYX Comparison

MGTX vs VYX Comparison

Compare MGTX & VYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$9.22

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo NCR Voyix Corporation

VYX

NCR Voyix Corporation

HOLD

Current Price

$8.15

Market Cap

994.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGTX
VYX
Founded
2015
1881
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
994.1M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
MGTX
VYX
Price
$9.22
$8.15
Analyst Decision
Buy
Buy
Analyst Count
8
6
Target Price
★ $27.75
$12.67
AVG Volume (30 Days)
819.2K
★ 2.5M
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 33.02
N/A
EPS
★ 1.30
N/A
Revenue
$81,391,000.00
★ $7,156,000,000.00
Revenue This Year
$314.19
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.09
★ N/A
Revenue Growth
★ 144.57
15.29
52 Week Low
$6.62
$6.02
52 Week High
$15.35
$12.02

Technical Indicators

Market Signals
Indicator
MGTX
VYX
Relative Strength Index (RSI) 31.90 58.88
Support Level $8.84 $7.51
Resistance Level $10.06 $8.46
Average True Range (ATR) 0.52 0.38
MACD 0.01 0.18
Stochastic Oscillator 6.12 77.34

Price Performance

Historical Comparison
MGTX
VYX

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in two reportable segments: Retail, and Restaurants. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The company derives maximum revenue from Retail segment. Geographically, the company operates in United States, Americas (excluding United States), Europe, Middle East and Africa, and Asia Pacific. It derives maximum revenue from United States.

Share on Social Networks: